Generic ActoPlus Met is used for treating type 2 diabetes. It is used along with diet and exercise. It works by decreasing the amount of sugar the liver produces and the intestines absorb. More info »
Generic Avandamet is a combination of two oral diabetes medicines that help control blood sugar levels. It is for people with type 2 diabetes who do not use daily insulin injections. More info »
Generic Avandaryl is a combination of two oral diabetes medicines that help control blood sugar levels. It is for people with type 2 diabetes who do not use daily insulin injections. More info »
Generic Glucovance is used for treating type 2 diabetes. It is used along with diet and exercise. It may be used alone or with other antidiabetic medicine. More info »
Generic Micronase is used for treating type 2 diabetes in patients who cannot control blood sugar levels by diet and exercise alone. It may be used alone or with other antidiabetic medicines. More info »
Generic Prandin is used for managing type 2 (non-insulin-dependent) diabetes. It is used in addition to diet and exercise to lower blood sugar in adults who cannot manage with diet, exercise, or diabetic medications alone. It may be used with other diabetes medicines. More info »
Generic Precose is used for treating type 2 diabetes in adults whose diabetes cannot be managed with diet alone. This medicine may be used alone, in combination with other oral diabetes medicines or with insulin. More info »
I have rec'd the order, and was pleased with every aspect of the order. I do look
forward to ordering in the future, so could you please keep in contact with me via
this email.
The diabetes care postcode lottery must end - The Guardian
The GuardianThe diabetes care postcode lottery must endThe GuardianEleven years ago the Department of Health set out a vision for diabetes services in England to be delivered by 2013.
Diabetes treatment is a postcode lottery - Telegraph.co.uk
Telegraph.
Glaxo Diabetes Drug Data Revealed Amid Hostile Takeover - BusinessWeek
Glaxo Diabetes Drug Data Revealed Amid Hostile TakeoverBusinessWeekBy Makiko Kitamura on May 24, 2012 GlaxoSmithKline Plc (GSK) will reveal detailed results today on an experimental treatment for diabetes that's part of the reason for a $2.
From one diabetic to another - Inquirer.net (blog)
From one diabetic to anotherInquirer.
MyNetDiary Adds Diabetes Tracking Service to Its High-Performing Lineup of ... - Seattle Post Intelligencer
MyNetDiary Adds Diabetes Tracking Service to Its High-Performing Lineup of .
